-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $25

Benzinga·11/10/2026 17:04:09
Listen to the news
Morgan Stanley analyst Craig Hettenbach maintains Hims & Hers Health (NYSE:HIMS) with a Equal-Weight and lowers the price target from $28 to $25.